Teachers Advisors LLC lifted its position in Colgate-Palmolive (NYSE:CL) by 6.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,237,892 shares of the company’s stock after buying an additional 126,978 shares during the quarter. Teachers Advisors LLC owned about 0.25% of Colgate-Palmolive worth $168,849,000 as of its most recent SEC filing.
Several other large investors have also recently added to or reduced their stakes in the stock. Captrust Financial Advisors bought a new position in shares of Colgate-Palmolive in the fourth quarter valued at $162,000. Raymond James & Associates grew its stake in shares of Colgate-Palmolive by 1.4% in the fourth quarter. Raymond James & Associates now owns 263,993 shares of the company’s stock valued at $19,919,000 after buying an additional 3,702 shares in the last quarter. California State Teachers Retirement System grew its stake in shares of Colgate-Palmolive by 0.5% in the fourth quarter. California State Teachers Retirement System now owns 1,575,003 shares of the company’s stock valued at $118,834,000 after buying an additional 8,043 shares in the last quarter. Two Sigma Investments LP grew its stake in shares of Colgate-Palmolive by 24.5% in the fourth quarter. Two Sigma Investments LP now owns 1,084,556 shares of the company’s stock valued at $81,830,000 after buying an additional 213,296 shares in the last quarter. Finally, Two Sigma Advisers LP grew its stake in shares of Colgate-Palmolive by 25.1% in the fourth quarter. Two Sigma Advisers LP now owns 1,513,711 shares of the company’s stock valued at $114,209,000 after buying an additional 303,690 shares in the last quarter. 73.87% of the stock is owned by institutional investors and hedge funds.
In other news, VP Henning I. Jakobsen sold 36,215 shares of Colgate-Palmolive stock in a transaction on Monday, February 5th. The stock was sold at an average price of $71.22, for a total transaction of $2,579,232.30. Following the completion of the sale, the vice president now owns 70,783 shares of the company’s stock, valued at $5,041,165.26. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Jennifer Daniels sold 902 shares of Colgate-Palmolive stock in a transaction on Tuesday, January 9th. The stock was sold at an average price of $75.82, for a total value of $68,389.64. Following the sale, the insider now directly owns 37,788 shares of the company’s stock, valued at approximately $2,865,086.16. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 463,082 shares of company stock valued at $32,983,130. Company insiders own 1.02% of the company’s stock.
Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, January 26th. The company reported $0.75 EPS for the quarter, hitting the Zacks’ consensus estimate of $0.75. Colgate-Palmolive had a net margin of 13.10% and a return on equity of 1,716.69%. The firm had revenue of $3.89 billion during the quarter, compared to analysts’ expectations of $3.92 billion. During the same period in the previous year, the business posted $0.75 earnings per share. The company’s revenue for the quarter was up 4.6% compared to the same quarter last year. equities analysts predict that Colgate-Palmolive will post 3.18 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, May 15th. Shareholders of record on Friday, April 20th will be given a dividend of $0.42 per share. This represents a $1.68 dividend on an annualized basis and a yield of 2.34%. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.40. The ex-dividend date of this dividend is Thursday, April 19th. Colgate-Palmolive’s payout ratio is 70.18%.
Several research firms recently weighed in on CL. Jefferies Group reissued a “hold” rating and issued a $79.00 target price on shares of Colgate-Palmolive in a research note on Friday, January 26th. Societe Generale cut shares of Colgate-Palmolive from a “hold” rating to a “sell” rating and set a $66.00 target price for the company. in a research note on Wednesday, November 29th. They noted that the move was a valuation call. Zacks Investment Research cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Friday, January 5th. Macquarie raised shares of Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 price objective for the company in a research report on Tuesday, December 19th. Finally, KeyCorp reaffirmed a “hold” rating on shares of Colgate-Palmolive in a research report on Saturday, November 25th. Three equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and five have assigned a buy rating to the stock. Colgate-Palmolive has a consensus rating of “Hold” and an average target price of $77.91.
TRADEMARK VIOLATION WARNING: “Teachers Advisors LLC Has $168.85 Million Position in Colgate-Palmolive (CL)” was originally posted by American Banking News and is the sole property of of American Banking News. If you are accessing this piece on another publication, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece can be viewed at https://www.americanbankingnews.com/2018/03/12/teachers-advisors-llc-has-168-85-million-position-in-colgate-palmolive-cl.html.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.